Canada Gives Samsung Bioepis A Further Ranibizumab Approval
Health Canada Nod For Byooviz Lucentis Rival Follows US And EU
• By David Wallace
Samsung Bioepis has the first Canadian approval for the ophthalmic biosimilar • Source: Bo Valentino / Alamy Stock Photo 
